Parkman Healthcare Partners’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-141,758
| Closed | -$971K | – | 90 |
|
|
2023
Q3 | $971K | Sell |
141,758
-51,839
| -27% | -$355K | 0.18% | 90 |
|
|
2023
Q2 | $2.01M | Buy |
193,597
+27,577
| +17% | +$286K | 0.35% | 76 |
|
|
2023
Q1 | $1.34M | Sell |
166,020
-81,139
| -33% | -$656K | 0.29% | 70 |
|
|
2022
Q4 | $3.89M | Buy |
247,159
+13,533
| +6% | +$213K | 1.04% | 39 |
|
|
2022
Q3 | $3.68M | Sell |
233,626
-71,217
| -23% | -$1.12M | 1.05% | 33 |
|
|
2022
Q2 | $4.26M | Sell |
304,843
-363,255
| -54% | -$5.07M | 1.57% | 23 |
|
|
2022
Q1 | $11.5M | Sell |
668,098
-357,424
| -35% | -$6.16M | 3.37% | 8 |
|
|
2021
Q4 | $14.9M | Sell |
1,025,522
-280,938
| -22% | -$4.08M | 3.29% | 7 |
|
|
2021
Q3 | $23.5M | Sell |
1,306,460
-195,000
| -13% | -$3.51M | 5.95% | 2 |
|
|
2021
Q2 | $26.4M | Sell |
1,501,460
-207,676
| -12% | -$3.65M | 5.76% | 1 |
|
|
2021
Q1 | $43.1M | Sell |
1,709,136
-166,200
| -9% | -$4.19M | 10% | 1 |
|
|
2020
Q4 | $12.1M | Buy |
1,875,336
+32,675
| +2% | +$211K | 3.11% | 5 |
|
|
2020
Q3 | $4.74M | Buy |
1,842,661
+145,304
| +9% | +$373K | 1.25% | 35 |
|
|
2020
Q2 | $2.75M | Buy |
1,697,357
+160,000
| +10% | +$259K | 0.77% | 44 |
|
|
2020
Q1 | $1.6M | Buy |
1,537,357
+1,312,357
| +583% | +$1.36M | 0.74% | 44 |
|
|
2019
Q4 | $425K | Buy |
+225,000
| New | +$425K | 0.12% | 66 |
|